Atomistry » Calcium » PDB 5iku-5jao » 5j4h
Atomistry »
  Calcium »
    PDB 5iku-5jao »
      5j4h »

Calcium in PDB 5j4h: Structure of Humanised Rada-Mutant HUMRADA22F in Complex with Indole- 6-Carboxylic Acid

Protein crystallography data

The structure of Structure of Humanised Rada-Mutant HUMRADA22F in Complex with Indole- 6-Carboxylic Acid, PDB code: 5j4h was solved by G.Fischer, M.Marsh, T.Moschetti, T.Sharpe, D.Scott, M.Morgan, H.Ng, J.Skidmore, A.Venkitaraman, C.Abell, T.L.Blundell, M.Hyvonen, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 50.16 / 1.37
Space group P 21 21 21
Cell size a, b, c (Å), α, β, γ (°) 40.459, 61.122, 87.767, 90.00, 90.00, 90.00
R / Rfree (%) 13.2 / 17

Other elements in 5j4h:

The structure of Structure of Humanised Rada-Mutant HUMRADA22F in Complex with Indole- 6-Carboxylic Acid also contains other interesting chemical elements:

Sodium (Na) 2 atoms

Calcium Binding Sites:

The binding sites of Calcium atom in the Structure of Humanised Rada-Mutant HUMRADA22F in Complex with Indole- 6-Carboxylic Acid (pdb code 5j4h). This binding sites where shown within 5.0 Angstroms radius around Calcium atom.
In total only one binding site of Calcium was determined in the Structure of Humanised Rada-Mutant HUMRADA22F in Complex with Indole- 6-Carboxylic Acid, PDB code: 5j4h:

Calcium binding site 1 out of 1 in 5j4h

Go back to Calcium Binding Sites List in 5j4h
Calcium binding site 1 out of 1 in the Structure of Humanised Rada-Mutant HUMRADA22F in Complex with Indole- 6-Carboxylic Acid


Mono view


Stereo pair view

A full contact list of Calcium with other atoms in the Ca binding site number 1 of Structure of Humanised Rada-Mutant HUMRADA22F in Complex with Indole- 6-Carboxylic Acid within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Ca404

b:19.9
occ:1.00
H A:THR145 2.5 13.8 0.6
H A:THR145 2.5 13.8 0.4
H A:GLY143 2.6 13.6 1.0
H A:GLN146 2.7 13.2 1.0
HG2 A:GLN146 2.9 17.9 1.0
HA2 A:GLY143 3.0 15.4 1.0
HB A:THR145 3.0 16.3 1.0
O A:HOH665 3.1 23.1 1.0
N A:THR145 3.2 11.5 1.0
N A:GLY143 3.2 11.3 1.0
H A:LYS144 3.3 13.2 0.6
CA A:GLY143 3.3 12.9 1.0
C A:GLY143 3.3 11.2 1.0
H A:LYS144 3.3 13.4 0.4
N A:LYS144 3.4 11.0 0.6
N A:LYS144 3.4 11.2 0.4
HA2 A:GLY141 3.5 23.7 1.0
N A:GLN146 3.5 11.0 1.0
O A:HOH725 3.5 48.1 1.0
H A:GLY141 3.7 23.8 1.0
HG2 A:LYS144 3.8 17.8 0.4
CB A:THR145 3.8 13.6 1.0
HG2 A:LYS144 3.8 21.3 0.6
CG A:GLN146 3.8 14.9 1.0
CA A:THR145 3.9 10.8 1.0
HB2 A:GLN146 3.9 15.7 1.0
O A:GLY143 4.0 11.8 1.0
CA A:GLY141 4.1 19.8 1.0
HE21 A:GLN146 4.2 29.5 1.0
C A:LYS144 4.2 11.7 0.4
C A:THR145 4.2 11.1 1.0
C A:GLY141 4.2 15.4 1.0
C A:LYS144 4.2 11.8 0.6
HG3 A:GLN146 4.2 17.9 1.0
HG3 A:LYS144 4.2 21.3 0.6
N A:GLY141 4.2 19.8 1.0
H A:SER142 4.2 16.0 1.0
HG3 A:LYS144 4.2 17.8 0.4
HA3 A:GLY143 4.3 15.4 1.0
CB A:GLN146 4.3 13.1 1.0
N A:SER142 4.3 13.3 1.0
CA A:LYS144 4.3 12.0 0.6
CA A:LYS144 4.3 12.1 0.4
OG1 A:THR145 4.4 18.5 1.0
CG A:LYS144 4.4 17.8 0.6
CG A:LYS144 4.4 14.9 0.4
CA A:GLN146 4.5 9.8 1.0
C A:SER142 4.5 11.1 1.0
HZ2 A:LYS144 4.6 27.0 0.6
O A:GLY141 4.7 17.5 1.0
HD13 A:ILE342 4.8 25.1 1.0
HA A:THR145 4.8 13.0 1.0
NE2 A:GLN146 4.8 24.6 1.0
O A:HOH621 4.8 27.7 1.0
HG A:SER142 4.9 21.1 1.0
CD A:GLN146 4.9 18.7 1.0
HD11 A:ILE342 4.9 25.1 1.0
H A:LEU147 4.9 12.3 1.0
HA3 A:GLY141 5.0 23.7 1.0
CB A:LYS144 5.0 15.1 0.6
HA A:GLN146 5.0 11.8 1.0
CG2 A:THR145 5.0 15.0 1.0
CB A:LYS144 5.0 13.8 0.4
HG22 A:THR145 5.0 18.0 1.0

Reference:

T.Moschetti, T.Sharpe, G.Fischer, M.E.Marsh, H.K.Ng, M.Morgan, D.E.Scott, T.L.Blundell, A.R Venkitaraman, J.Skidmore, C.Abell, M.Hyvonen. Engineering Archeal Surrogate Systems For the Development of Protein-Protein Interaction Inhibitors Against Human RAD51. J.Mol.Biol. V. 428 4589 2016.
ISSN: ESSN 1089-8638
PubMed: 27725183
DOI: 10.1016/J.JMB.2016.10.009
Page generated: Wed Jul 9 07:01:45 2025

Last articles

Fe in 2YXO
Fe in 2YRS
Fe in 2YXC
Fe in 2YNM
Fe in 2YVJ
Fe in 2YP1
Fe in 2YU2
Fe in 2YU1
Fe in 2YQB
Fe in 2YOO
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy